Federal prosecutors alleged that CVS ignored dangerous prescription patterns, understaffed pharmacies, and billed government healthcare programs for invalid controlled-substance prescriptions. PROVIDENCE, RI – October 14, 2026 (STL.News) CVS Pharmacy Inc. and related corporate entities have agreed to pay $315 million to resolve sweeping federal allegations that the nationwide pharmacy chain unlawfully dispensed opioids and other controlled substances while seeking reimbursement from taxpayer-funded healthcare programs. The settlement, announced October 13 by the U.S. Department of Justice, concludes a major civil enforcement action over alleged violations of the Controlled Substances Act and the False Claims Act from October 17, 2013, through
Source: Read Original Article
